The Biology and Pharmacology of Calcium Channel α2-δ Proteins Pfizer satellite symposium to the 2003 Society for Neuroscience Meeting Sheraton New Orleans Hotel New Orleans, LA November 10, 2003

CNS Drug Reviews

Volumn 10, Issue 2, 2004, Pages 183-188

  Taylor, Charles P ^a   Catterall, William A ^b   Hofmann, Franz ^c   Luo, Z David ^d   Wustrow, David J ^a   Vasko, Michael ^e   Field, Mark ^f   Baron, Scott ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Analgesics; Anticonvulsants; Calcium channels; Gabapentin; Pregabalin; R217A mice; 2 Proteins

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CALCIUM CHANNEL; GABAPENTIN; PREGABALIN; SODIUM CHANNEL;

CHANNEL GATING; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC NEUROPATHY; DRUG BIOAVAILABILITY; DRUG PROTEIN BINDING; EPILEPSY; GENERALIZED ANXIETY DISORDER; HUMAN; MEMBRANE DEPOLARIZATION; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NONHUMAN; PAIN; PERIKARYON; POSTHERPETIC NEURALGIA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STRUCTURE ACTIVITY RELATION; SYMPOSIUM;

EID: 3042727921     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2004.tb00012.x     Document Type: Conference Paper

References (0)